José Luís Morales‐Rull

Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

Joan Carles Trullàs, José Luís Morales‐Rull, Jesús Casado et al. · European Heart Journal · 2022 · 296 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Thomas L Holland, Adit A. Ginde, Roger Paredes et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +4

Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction

Francisco Javier Carrasco-Sánchez, Óscar Aramburu‐Bodas, Prado Salamanca‐Bautista et al. · International Journal of Cardiology · 2013 · 78 citations

Medicine, Cardiology, Internal Medicine +11

Rationale and Design of the “Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:” A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure

Joan Carles Trullàs, José Luís Morales‐Rull, Jesús Casado et al. · Journal of Cardiac Failure · 2015 · 50 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Acute Decompensated Heart Failure

Sergio Manzano‐Fernández, Pedro J. Flores‐Blanco, Juan Ignacio Pérez‐Calvo et al. · Journal of Cardiac Failure · 2013 · 44 citations

Medicine, Biostatistics, Cardiology +12